sales@duogateregulatory.com
Regulatory Updates

ASEAN Agrees on a Single Submission Model for Devices

ASEAN Agrees on a Single Submission Model for Devices

ASEAN Agrees in Principle to a Single Submission Model for Medical Devices, with Malaysia as the Entry Point

There is news out of Kuala Lumpur this week that manufacturers selling into Southeast Asia will want to know about.
At the 1st ASEAN Roundtable Discussion on Medical Devices, held alongside the 17th ASEAN Health Ministers Meeting, member states agreed in principle to support a phased Single Submission Model for pre-market approvals. The announcement was shared publicly by Ts. Dr. Muralitharan Paramasua, Chief Executive Officer of Malaysia’s Medical Device Authority (MDA).

What was agreed

Four points came out of the roundtable:
  • One dossier, shared across the region. Applicants would submit a single technical dossier through an agreed regional framework, with assessment work shared between participating member states.
  • Malaysia as the coordinating entry point. Malaysia would receive submission dossiers in the initial phase and distribute them to the regulatory authorities of other member states.
  • Less duplication. The model is intended to remove repeated assessments of the same product, make better use of regulatory resources, and shorten approval timelines.
  • National authority stays where it is. Each member state keeps full decision-making power over registrations under its own laws.
The ASEAN Medical Device Committee and the ASEAN Secretariat will now develop the technical and operational guidelines. The next meeting is scheduled for Vientiane, Lao PDR, in October.

Worth keeping in perspective

This is an agreement in principle, not a live pathway. Nothing changes about how you register a device today.
Health Minister Dzulkefly Ahmad noting that member states are at different stages of readiness. Some are still working through their regulations and legal frameworks, while others, including Singapore and the Philippines, are further ahead. A phased rollout is the realistic expectation, and the guidelines being drafted now will determine what it actually looks like in practice.

What it means if you are looking at Malaysia

The detail we would draw your attention to is Malaysia’s proposed role as the coordinating entry point.
If the model develops as described, the dossier you prepare for Malaysia becomes the dossier that travels. For a manufacturer deciding where to start in Southeast Asia, that is a meaningful argument for starting here rather than treating Malaysia as a later addition. It also raises the value of getting your Malaysian file right the first time, because a file built to a coordinating regulator’s standard is one you can reuse.
Malaysia was already a sensible first market: published requirements, an English-language process, and no need for a foreign manufacturer to incorporate locally as long as an Authorised Representative holds the registration.

How DuoGate can help

We are a regulatory consultancy based in Penang, working with manufacturers on medical devices and cosmetics. We act as an independent Authorised Representative and license holder, prepare and submit registrations to the MDA.
If you are weighing up Malaysia as your entry point into ASEAN, we are happy to look at your product and tell you what it would involve.
Talk to DuoGate about entering the Malaysian market →
 

Frequently Asked Questions

What is the ASEAN Single Submission Model?
It is a proposed regional framework allowing a manufacturer to submit one technical dossier for pre-market approval, with assessment work shared among participating ASEAN member states. It was agreed in principle at the 1st ASEAN Roundtable Discussion on Medical Devices in September 2026.

Is the Single Submission Model in effect now?
No. Member states have agreed in principle to a phased model. The ASEAN Medical Device Committee and the ASEAN Secretariat are developing the technical and operational guidelines, with the next meeting in Vientiane in October 2026.

What is Malaysia’s role?
Malaysia has been proposed as the coordinating entry point for initial implementation, receiving technical dossiers and distributing them to the regulatory authorities of other member states.

Will each country still decide on its own registrations?
Yes. Member states retain full national decision-making authority over medical device registration in accordance with their own laws.